- Home
- SPKL vs VXRT Comparison
SPKL vs VXRT Comparison
Compare SPKL & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPKL
- VXRT
- Stock Information
- Founded
- SPKL 2021
- VXRT N/A
- Country
- SPKL United States
- VXRT United States
- Employees
- SPKL N/A
- VXRT N/A
- Industry
- SPKL
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPKL
- VXRT Health Care
- Exchange
- SPKL Nasdaq
- VXRT Nasdaq
- Market Cap
- SPKL 170.5M
- VXRT 200.3M
- IPO Year
- SPKL 2023
- VXRT N/A
- Fundamental
- Price
- SPKL $10.56
- VXRT $0.79
- Analyst Decision
- SPKL
- VXRT Strong Buy
- Analyst Count
- SPKL 0
- VXRT 2
- Target Price
- SPKL N/A
- VXRT $3.00
- AVG Volume (30 Days)
- SPKL 14.8K
- VXRT 1.0M
- Earning Date
- SPKL 01-01-0001
- VXRT 10-31-2024
- Dividend Yield
- SPKL N/A
- VXRT N/A
- EPS Growth
- SPKL N/A
- VXRT N/A
- EPS
- SPKL 0.12
- VXRT N/A
- Revenue
- SPKL N/A
- VXRT $13,928,000.00
- Revenue This Year
- SPKL N/A
- VXRT $67.68
- Revenue Next Year
- SPKL N/A
- VXRT N/A
- P/E Ratio
- SPKL $86.48
- VXRT N/A
- Revenue Growth
- SPKL N/A
- VXRT 577.76
- 52 Week Low
- SPKL $10.07
- VXRT $0.52
- 52 Week High
- SPKL $11.57
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- SPKL 67.33
- VXRT 45.41
- Support Level
- SPKL $10.45
- VXRT $0.77
- Resistance Level
- SPKL $11.57
- VXRT $0.83
- Average True Range (ATR)
- SPKL 0.12
- VXRT 0.04
- MACD
- SPKL 0.01
- VXRT -0.00
- Stochastic Oscillator
- SPKL 9.01
- VXRT 32.08
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.